• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

GraphPad Software Acquires SnapGene, Forms Insightful Science

Share:

August 19, 2019

GraphPad Software announced today it has acquired SnapGene, a leading bioinformatics software solution.

SnapGene is the easiest way to plan, visualize, and document molecular biology procedures. It was developed by Benjamin Glick, Ph.D., a professor at the University of Chicago, frustrated by inefficiencies and inadequate procedures that he experienced in research labs. Since its launch in 2012, the company has seen rapid adoption of its innovative DNA cloning solutions designed to enhance the research workflow.

A parent entity, Insightful Science, was formed to support the growing portfolio of brands that now includes SnapGene. SnapGene is the second bioinformatics technology brand acquired by the company this year. Other products within the portfolio include GraphPad Prism and Geneious DNA data analysis solutions, Geneious Prime and Geneious Biologics.

“We are honored to welcome SnapGene into our growing portfolio,” said Thomas Swalla, CEO of Insightful Science. “The company has already had a phenomenal impact advancing research at leading institutions and biotech and pharmaceutical companies. We look forward to empowering even more scientists with this technology, and further serving and supporting the global scientific community.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“Our vision for SnapGene has always been to accelerate scientific discovery,” said Benjamin Glick, Founder and Chief Scientist of SnapGene. “After getting to know the team at Insightful Science, it is clear to us that they share this mission. We are proud and excited to be a part of this organization, alongside other industry-leading solutions. This partnership will help us advance our mission further.”

“The Insightful Science brands share powerful attributes,” continued Swalla. “They all deliver remarkable user experiences, great support, and high-quality educational content. We believe it’s the combination of these attributes that have helped put these brands at the core of scientific research around the world.”

All the companies within Insightful Science will continue to operate and serve customers under their respective brands. Visit www.insightfulscience.com for more information.

Date: August 19, 2019

Source: PR Newswire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Digital Pharmacy Alto Scores $200M from Softbank Vision FundDigital Pharmacy Alto Scores $200M from Softbank Vision Fund
  • Pfizer Bets $2.26 Billion on Trillium’s Checkpoint InhibitorsPfizer Bets $2.26 Billion on Trillium’s Checkpoint Inhibitors
  • Sartorius Acquires Cell Culture Specialist Xell AGSartorius Acquires Cell Culture Specialist Xell AG
  • Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 TestCue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test
  • Biotechnology and Medicine Startups Top the Innovators Under 35 Europe ListBiotechnology and Medicine Startups Top the Innovators Under 35 Europe List
  • VC Firm General Catalyst Partners Lands First NHS Trust Partnership in UKVC Firm General Catalyst Partners Lands First NHS Trust Partnership in UK
  • HotSpot Therapeutics Announces Acquisition Of Macroceutics, Inc.HotSpot Therapeutics Announces Acquisition Of Macroceutics, Inc.
  • Cigna Seeks Sale of Group Benefits Insurance Business, Valued as High as $6 BillionCigna Seeks Sale of Group Benefits Insurance Business, Valued as High as $6 Billion

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications